LORICRIN and neoplasm: Interestingly, the expression patterns of BRG1/ACTL6A and loricrin were completely different in melanoma, another type of skin tumour derived from melanocytes (Supplementary Fig. 1), confirming a tumour-specific regulatory function of uc.291 and BRG1 in keratinocyte-derived malignancies.